ORCID as entered in ROS

Select Publications
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
2023, 'Chemotherapy-Induced Cranial Nerve Damage', in Cranial Nerves in Neurology A Comprehensive and Systematic Evaluation of Cranial Nerves Pathology and Specific Conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23
,2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138
,2023, 'Amyotrophic lateral sclerosis', in Advances in Magnetic Resonance Technology and Applications, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2
,2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1
,2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia the Neuroscience of Dementia Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5
,2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press, pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019
,2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918
,2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Routledge, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9
,2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders, Springer International Publishing, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8
,2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235
,2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9
,2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138
,, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376
2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2
,2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b
,2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3
,2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104
,2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181
,2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403
,2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943
,2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy 2 Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9
,2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9
,2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129
,2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366
,2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences Volumes 1 4, pp. V2-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3
,2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642
,1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154
,1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53
,2025, 'An Annotated Multi-Site and Multi-Contrast Magnetic Resonance Imaging Dataset for the study of the Human Tongue Musculature', Scientific Data, 12, http://dx.doi.org/10.1038/s41597-025-05092-8
,2025, 'Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-01570-6
,2025, 'Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement', Molecular Neurodegeneration, 20, http://dx.doi.org/10.1186/s13024-025-00820-5
,2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): protocol for a process evaluation of a clinical trial', Trials, 26, http://dx.doi.org/10.1186/s13063-025-08784-z
,2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial', Trials, 26, http://dx.doi.org/10.1186/s13063-024-08464-4
,2025, 'Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis', Clinical Neurophysiology, 174, pp. 105 - 113, http://dx.doi.org/10.1016/j.clinph.2025.03.044
,2025, 'Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort (P10-11.033)', Neurology, 104, http://dx.doi.org/10.1212/wnl.0000000000212523
,2025, 'Amyotrophic lateral sclerosis represents corticomotoneuronal system failure', Muscle and Nerve, 71, pp. 499 - 511, http://dx.doi.org/10.1002/mus.28290
,2025, 'Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis', Brain, 148, pp. 1169 - 1179, http://dx.doi.org/10.1093/brain/awae317
,2025, 'Utility of the Gold Coast criteria for amyotrophic lateral sclerosis: Experience with fast progressors', Journal of the Neurological Sciences, 470, http://dx.doi.org/10.1016/j.jns.2025.123417
,2025, 'Quantifying neurodegeneration within subdivisions of core motor pathways in amyotrophic lateral sclerosis using diffusion MRI', Journal of Neurology, 272, http://dx.doi.org/10.1007/s00415-025-12920-9
,2025, 'Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis', Eneurologicalsci, 38, http://dx.doi.org/10.1016/j.ensci.2025.100559
,2025, 'Muscle ultrasound aids diagnosis in amyotrophic lateral sclerosis', Clinical Neurophysiology, 170, pp. 234 - 243, http://dx.doi.org/10.1016/j.clinph.2024.11.008
,2025, 'Neurophysiological assessment of cortical motor function: A direct comparison of methodologies', Clinical Neurophysiology, 170, pp. 14 - 21, http://dx.doi.org/10.1016/j.clinph.2024.12.001
,2025, 'Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale', Clinical and Experimental Rheumatology, 43, pp. 316 - 325, http://dx.doi.org/10.55563/clinexprheumatol/zvffa0
,2025, 'The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations', Brain Sciences, 15, http://dx.doi.org/10.3390/brainsci15020195
,2025, 'Transforming amyotrophic lateral sclerosis into a liveable disease', Lancet Neurology, 24, pp. 100 - 101, http://dx.doi.org/10.1016/S1474-4422(24)00523-4
,2025, 'Post-infectious acute cerebellar ataxia in a young adult', BMJ Case Reports, 18, http://dx.doi.org/10.1136/bcr-2024-262043
,2025, 'Stroke is not optional for neurologists', Practical Neurology, 25, pp. 2 - 3, http://dx.doi.org/10.1136/pn-2024-004230
,2025, 'Amyotrophic lateral sclerosis established as a multistep process across phenotypes', European Journal of Neurology, 32, http://dx.doi.org/10.1111/ene.16532
,